Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
10 Juillet 2023 - 10:30PM
Half-Year Report on the DBV Technologies Liquidity Contract with
ODDO BHF
AMF Regulated
InformationMontrouge, France, July 10, 2023
Half-Year Report on the DBV Technologies
Liquidity Contract with ODDO BHF
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today issued the Half-Year report on its
liquidity contract with ODDO BHF.
Under the liquidity contract between DBV
Technologies and ODDO BHF, the following assets appeared on the
liquidity account as of June 30, 2023:
- 149,972 DBV Technologies
shares,
- € 317,981.
When the liquidity contract with ODDO BHF was
implemented, as of July 1, 2018, the following assets were included
in the liquidity account:
- 41,159 DBV Technologies
shares,
- € 432,367.25.
Over the period from January 1, 2023, to June
30, 2023, the following transactions were executed:
- 1,326 buy transactions,
- 1,213 sales transactions.
Over this same period, the volumes traded
represented:
- 432,837 shares and € 1,330,080 on
purchases,
- 432,658 shares and € 1,355,257 on
sales.
About DBV Technologies
DBV Technologies is developing Viaskin™, an
investigational proprietary technology platform with broad
potential applications in immunotherapy. Viaskin is based on
epicutaneous immunotherapy, or EPIT™, and is DBV Technologies’
method of delivering biologically active compounds to the immune
system through intact skin. With this new class of non-invasive
product candidates, the Company is dedicated to safely transforming
the care of food allergic patients. DBV Technologies’ food
allergies programs include ongoing clinical trials of Viaskin
Peanut. DBV Technologies has global headquarters in Montrouge,
France, and North American operations in Basking Ridge, NJ. The
Company’s ordinary shares are traded on segment B of Euronext Paris
(Ticker: DBV, ISIN code: FR0010417345) and the Company’s ADSs (each
representing one-half of one ordinary share) are traded on the
Nasdaq Global Select Market (Ticker: DBVT).
DBV Technologies (EU:DBV)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
DBV Technologies (EU:DBV)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024